Table 1.
Demographic and endoscopic characteristics of individuals with and without VG
| Non-VG group | VG group | ||
|---|---|---|---|
| Characteristic | (n = 269) | (n = 352) | P-value |
| Age (years), median [IQR] | 69 [63–75] | 70 [64–74] | 0.73 |
| Male gender, n (%) | 106 (39.4) | 162 (46.0) | 0.1 |
| BMI (kg/m2), median [IQR] | 21.8 [19.7–23.8] | 22.6 [20.7–25.0] | <0.01 |
| Total cholesterol (mmol/L), median [IQR] | 5.28 [4.66–5.98] | 5.15 [4.58–5.75] | 0.18 |
| Albumin (g/L), median [IQR] | 43.0 [40.0–45.0] | 43.0 [40.0–45.0] | 0.96 |
| Gastric mucosal atrophy, n (%) | |||
| No atrophy | 46 (17.1) | 84 (23.8) | |
| Closed-type atrophy | 109 (40.5) | 149 (42.3) | 0.04 |
| Open-type atrophy | 114 (42.4) | 119 (33.8) | |
| Reflux esophagitis, n (%) | 24 (8.9) | 89 (25.2) | <0.01 |
| Barrett’s esophagus, n (%) | 40 (14.8) | 80 (22.7) | 0.01 |
| Bile-colored gastric juice, n (%) | 43 (16.0) | 53 (15.0) | 0.75 |
| H. pylori infection, n (%) | |||
| Positive | 138 (51.3) | 42 (11.9) | |
| Negative | |||
| Without a history of eradication | 77 (28.6) | 153 (43.4) | |
| After eradication | 54 (20.0) | 157 (44.6) | <0.001 |
IQR, interquartile range; BMI, body mass index; VG, verrucous gastritis; non-VG, without verrucous gastritis.